Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,775 | 3 | 51.8% |
| Food and Beverage | $2,245 | 57 | 24.4% |
| Travel and Lodging | $1,971 | 4 | 21.4% |
| Consulting Fee | $200.00 | 1 | 2.2% |
| Education | $26.90 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Accuray Incorporated | $4,634 | 5 | $0 (2024) |
| RefleXion Medical, Inc. | $1,559 | 5 | $0 (2024) |
| Blue Earth Diagnostics Limited | $1,375 | 5 | $0 (2023) |
| Dendreon Pharmaceuticals LLC | $395.42 | 13 | $0 (2022) |
| Augmenix, Inc. | $266.76 | 4 | $0 (2018) |
| Covidien LP | $200.00 | 1 | $0 (2017) |
| Janssen Biotech, Inc. | $197.79 | 7 | $0 (2022) |
| PROGENICS PHARMACEUTICALS, INC. | $119.26 | 5 | $0 (2024) |
| Teleflex LLC | $84.43 | 2 | $0 (2024) |
| Novocure Inc. | $71.90 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,799 | 11 | Accuray Incorporated ($4,634) |
| 2023 | $230.16 | 8 | Progenics Pharmaceuticals, Inc. ($95.79) |
| 2022 | $1,851 | 17 | RefleXion Medical, Inc. ($1,515) |
| 2021 | $108.00 | 5 | Medtronic, Inc. ($27.08) |
| 2020 | $49.23 | 3 | Dendreon Pharmaceuticals LLC ($48.49) |
| 2019 | $1,323 | 3 | Blue Earth Diagnostics Limited ($1,296) |
| 2018 | $296.26 | 8 | Augmenix, Inc. ($214.03) |
| 2017 | $561.49 | 12 | Dendreon Pharmaceuticals LLC ($212.71) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/09/2024 | RefleXion Medical, Inc. | REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) | Food and Beverage | In-kind items and services | $44.23 | General |
| Category: RADIOTHERAPY EQUIPMENT | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Oncology | ||||||
| 06/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: Oncology | ||||||
| 03/09/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $21.25 | General |
| 02/27/2024 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $26.83 | General |
| Category: Oncology | ||||||
| 02/09/2024 | PROGENICS PHARMACEUTICALS, INC. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 01/31/2024 | Accuray Incorporated | CyberKnife System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: RADIATION ONCOLOGY | ||||||
| 01/24/2024 | Accuray Incorporated | TomoTherapy System (Device) | Food and Beverage | Cash or cash equivalent | $121.76 | General |
| Category: RADIATION ONCOLOGY | ||||||
| 01/23/2024 | Accuray Incorporated | CyberKnife System (Device), TomoTherapy System | Food and Beverage | Cash or cash equivalent | $381.65 | General |
| Category: RADIATION ONCOLOGY | ||||||
| 01/22/2024 | Accuray Incorporated | CyberKnife System (Device), TomoTherapy System | Travel and Lodging | Cash or cash equivalent | $630.54 | General |
| Category: RADIATION ONCOLOGY | ||||||
| 01/18/2024 | Accuray Incorporated | CyberKnife System (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,000.00 | General |
| Category: RADIATION ONCOLOGY | ||||||
| 10/27/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 10/25/2023 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $63.18 | General |
| Category: Interventional Urology | ||||||
| 10/17/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 08/15/2023 | Blue Earth Diagnostics Limited | Axumin (Drug), POSLUMA | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Diagnostic Imaging | ||||||
| 07/21/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 06/16/2023 | Progenics Pharmaceuticals, Inc. | PYLARIFY (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: RADIOPHARMACEUTICAL | ||||||
| 04/11/2023 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Diagnostic Imaging | ||||||
| 01/26/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: Oncology | ||||||
| 11/16/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Oncology | ||||||
| 11/14/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Oncology | ||||||
| 10/28/2022 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Education | In-kind items and services | $14.11 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/13/2022 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: ONCOLOGY | ||||||
| 08/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Oncology | ||||||
| 08/11/2022 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 41 | 3,696 | 17,212 | $20.3M | $3.8M |
| 2022 | 35 | 3,750 | 15,851 | $20.8M | $3.8M |
| 2021 | 32 | 2,610 | 13,148 | $13.5M | $2.4M |
| 2020 | 29 | 2,840 | 15,920 | $17.4M | $3.1M |
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G6015 | Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session | Office | 2023 | 141 | 3,423 | $6.6M | $996,526 | 15.1% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 97 | 907 | $1.7M | $428,533 | 25.9% |
| 77301 | High precision radiation therapy planning | Office | 2023 | 190 | 219 | $1.7M | $325,857 | 19.2% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Office | 2023 | 137 | 3,271 | $2.3M | $323,612 | 13.9% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 254 | 268 | $1.0M | $319,609 | 31.8% |
| 77373 | Cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 67 | 353 | $2.1M | $289,576 | 13.9% |
| A9596 | Gallium ga-68 gozetotide, diagnostic, (illuccix), 1 millicurie | Office | 2023 | 62 | 362 | $1.0M | $262,375 | 25.3% |
| 77427 | Radiation treatment management, 5 treatment sessions | Office | 2023 | 202 | 675 | $463,907 | $107,381 | 23.1% |
| G6012 | Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 6-10 mev | Office | 2023 | 44 | 531 | $462,299 | $101,365 | 21.9% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Office | 2023 | 191 | 222 | $397,695 | $84,175 | 21.2% |
| 77300 | Calculation of radiation therapy dose | Office | 2023 | 214 | 1,466 | $362,827 | $79,816 | 22.0% |
| 77336 | Continuing radiation therapy consultation per week | Office | 2023 | 249 | 881 | $280,167 | $62,865 | 22.4% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 98 | 111 | $109,538 | $45,510 | 41.5% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Office | 2023 | 80 | 101 | $198,776 | $36,229 | 18.2% |
| 77263 | Complex radiation therapy planning | Office | 2023 | 236 | 259 | $159,680 | $36,202 | 22.7% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 237 | 347 | $199,967 | $35,175 | 17.6% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Office | 2023 | 58 | 62 | $160,361 | $33,420 | 20.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 137 | 137 | $102,751 | $24,410 | 23.8% |
| 77295 | 3d radiation therapy planning | Office | 2023 | 37 | 54 | $140,587 | $20,524 | 14.6% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Office | 2023 | 59 | 76 | $73,409 | $16,556 | 22.6% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Office | 2023 | 19 | 221 | $90,826 | $13,502 | 14.9% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 14 | 102 | $136,626 | $13,359 | 9.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 242 | 332 | $51,965 | $13,247 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 72 | 87 | $45,525 | $12,317 | 27.1% |
| 77771 | High dose radiation therapy, 2-12 channels | Office | 2023 | 14 | 23 | $50,285 | $10,397 | 20.7% |
About Dr. Constantine Mantz, MD
Dr. Constantine Mantz, MD is a Therapeutic Radiology healthcare provider based in Cape Coral, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1396743290.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Constantine Mantz, MD has received a total of $9,218 in payments from pharmaceutical and medical device companies, with $4,799 received in 2024. These payments were reported across 67 transactions from 19 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4,775).
As a Medicare-enrolled provider, Mantz has provided services to 12,896 Medicare beneficiaries, totaling 62,131 services with total Medicare billing of $13.0M. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Practice Information
- Specialty Therapeutic Radiology
- Location Cape Coral, FL
- Active Since 07/13/2005
- Last Updated 02/25/2025
- Taxonomy Code 2085R0203X
- Entity Type Individual
- NPI Number 1396743290
Products in Payments
- CyberKnife System (Device) $4,512
- REFLEXION MEDICAL RADIOTHERAPY SYSTEM (Device) $1,559
- Axumin (Drug) $1,375
- PROVENGE (Drug) $409.24
- SpaceOAR (Device) $266.76
- ERLEADA (Drug) $152.27
- TomoTherapy System (Device) $121.76
- PYLARIFY (Drug) $119.26
- UROLIFT (Device) $63.18
- Brachytherapy Source (Device) $61.32
- Optune (Device) $47.34
- Xtandi (Drug) $46.32
- Nubeqa (Drug) $34.44
- Xofigo (Drug) $31.46
- GENERAL THERAPIES (Device) $27.14
- OSTEOCOOL RF ABLATION (Device) $27.08
- Erleada (Drug) $23.36
- ZYTIGA (Drug) $22.16
- LUTATHERA (Drug) $17.74
- PLUVICTO (Drug) $17.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.